Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedUpdated PubMed-related text to state that publications are auto-filled from PubMed and may not be about the study, and revised the version from v3.2.0 to v3.3.2; the older PubMed-generated wording was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page removed a government funding/operating-status notice, and this change does not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedStudy location label updated from 'Tainan City, Taiwan' to 'Tainan, Taiwan'. This affects how the site is identified and displayed for recruitment and documentation on the study page.SummaryDifference0.1%

- Check49 days agoChange DetectedNo significant changes detected between the two screenshots; the Study Details page for NCT03510871 remains unchanged in content and layout.SummaryDifference0.5%

- Check70 days agoChange DetectedUpdate includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedAdded a specific PubMed-listed publication entry and a v3.1.0 revision note, replacing the previous v3.0.2.SummaryDifference5%

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.